你有没有想过，一个人高位截瘫8年，只靠"想"，就能打游戏、网购，甚至控制家里的智能电器？ 最近，国内首款、也是全球第二款内置电池的脑机接口产品，公布了临床试验结果，上面这些设想，已 经成真了。 这款产品由脑虎科技自主研发，临床试验由华山医院毛颖、陈亮教授团队牵头完成。 从这一点就能清晰感受到，中美在脑机接口的赛道上，走的根本是两条路。 一边追求极致性能，一边专注安全可行，俨然一场硬科技时代的路线对决。 最厉害的一点是，这款产品做到了"三全"，即全植入、全无线和全功能。 这个"三全"设计，不仅是技术上的突破，更是从身体、社交、能力三个维度，帮助重度残疾患者重新找 回作为"人"的尊严和主动权： 全植入，从物理上杜绝感染风险，同时也隐藏了疾病的痕迹，保护了用户的身体自主与隐私尊严。 全无线，给了用户行动和场景的自由，让他们能在最少限制下重建社会联系、找回自信。 全功能加上开放的操作系统，则让用户不再是被动受助者，而是能主动掌控生活，从"生存"转向"生 活"。 这里要特别提一下脑虎科技对电池的处理方式。 和马斯克的Neuralink把电池塞进脑袋里不同——那样会牺牲部分数据来防止电池发热伤到大脑——脑虎 科技创新地把 ...

12日，A股全线飙升，沪指午后涨超1%，创业板指涨近2%，北证50指数大涨超5%；港股亦走高，恒生 指数涨超1%，恒生科技指数涨超3%。 具体来看，两市股指早盘震荡上扬，午后再度攀升，沪指涨超1%，续创逾10年新高；创业板指逼近 3400点，创4年新高。截至收盘，沪指涨1.09%报4165.29点，续创逾10年新高；深证成指、创业板指涨 近2%，北证50指数涨5.35%，沪深北三市合计成交约3.64万亿元，突破前期高点，创历史新纪录。 全A超4100股飘红，逾200股涨停。AI应用概念集体爆发，万兴科技（300624）、海天瑞声、昆仑万维 （300418）等涨停，星环科技尾盘亦涨停续创新高；商业航天概念热度不减，邵阳液压（301079）4日 大涨超100%，创历史新高；天力复合、铂力特、理工导航等均创新高；脑机接口概念午后拉升，道氏 技术（300409）20%涨停，倍益康、爱朋医疗（300753）等涨超10%。此外，16倍大牛股天普股份 （605255）复牌跌停。 脑机接口概念活跃 脑机接口概念盘中强势拉升，截至收盘，道氏技术20%涨停，创历史新高，熵基科技（301330）涨超 17%亦创新高，倍益康、爱朋医 ...

12日，A股全线飙升，沪指午后涨超1%，创业板指涨近2%，北证50指数大涨超5%；港股亦走 高，恒生指数涨超1%，恒生科技指数涨超3%。 全A超4100股飘红，逾200股涨停。AI应用概念集体爆发，万兴科技、海天瑞声、昆仑万维等涨 停，星环科技尾盘亦涨停续创新高；商业航天概念热度不减，邵阳液压4日大涨超100%，创历史 新高；天力复合、铂力特、理工导航等均创新高；脑机接口概念午后拉升，道氏技术20%涨停， 倍益康、爱朋医疗等涨超10%。此外，16倍大牛股天普股份复牌跌停。 值得注意的是，今日A股市场共有4只个股成交额超过200亿元，其中蓝色光标（300058）全日成 交235.9亿元，位居A股成交额首位。 AI应用概念火爆 AI应用概念盘中集体爆发，个股掀涨停潮。截至收盘，众诚科技、星图测控、流金科技30%涨 停，蓝色光标、易点天下、万兴科技、海天瑞声、昆仑万维、值得买等均涨停。 | 代码 | 名称 | � | 涨幅% | 现价 | 涨跌 | 买价 | 卖价 | 总量 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 920207 父诚科技 ...

Equity Market Review and Outlook - The A-share market continued its upward trend in the first week of 2026 (January 5-9), with the Shanghai Composite Index achieving a 16-day winning streak and surpassing 4100 points. Major broad-based indices generally rose and reached new highs during the week [1][5] - Market trading remained highly active, with Friday's trading volume returning to the peak of 3 trillion yuan, and the margin financing and securities lending scale exceeding 2.6 trillion yuan, setting a new historical high [1][5] - The market's robust performance was primarily driven by bottom-up growth themes, particularly in technology sectors such as AI applications, commercial aerospace, and brain-computer interfaces, with small and mid-cap stocks significantly outperforming [1][5] - The brain-computer interface sector was notably active, driven by expectations of Neuralink's mass production and the establishment of domestic companies, alongside positive sentiment from the "14th Five-Year Plan" [5][6] - The commercial aerospace sector also saw continuous attention due to an IPO boom and supportive policies, with funds increasingly focusing on sub-sectors like space computing and solar power in space [6] Fixed Income Market Review and Outlook - The bond market experienced a "V-shaped reversal" during the week, with the 1-year government bond yield declining by 4.35 basis points to 1.29%, while the 10-year and 30-year government bond yields rose by 3.55 basis points to 1.88% and 4.95 basis points to 2.30%, respectively [2][9] - The bond market sentiment showed slight stabilization, but the likelihood of interest rate cuts in the medium term remains low, and further monetary policy easing is not expected [2][9] - Despite the better-than-expected implementation of new public fund fee regulations, the bond market lacks positive catalysts, and with the ongoing spring rally in the equity market, the bond market may experience short-term rebounds but is likely to maintain a neutral stance in the medium term [2][9] Macro Economic Outlook - The U.S. job market shows resilience but also structural pressures, with inflation data expected to have limited risk of a strong rebound. The market has already priced in the likelihood of the Federal Reserve not cutting interest rates in January [7][8] - Overall market liquidity is neutral to optimistic, with potential continued inflows of external funds due to profit-taking effects, suggesting that the market may continue its upward trend [7][8]

Core Viewpoint - The recent surge in the brain-computer interface (BCI) sector in the A-share market reflects a significant shift from laboratory research to clinical application, marking a milestone in the integration of life sciences and engineering technology [1] Group 1: Domestic Breakthroughs - The domestic BCI field has seen a rapid increase in clinical achievements, highlighted by Brain Tiger Technology's launch of the first fully implanted, wireless, and fully functional BCI product, which successfully enabled a high-level paraplegic patient to control web browsing through thought [2] - This "three-in-one" product addresses critical issues such as infection risks associated with external systems and allows patients to connect with various devices, creating an "extended body" ecosystem [2] - Clinical data shows that patients achieved thought control within five days post-surgery, with a decoding rate of 5.2 BPS, comparable to international standards [2] Group 2: Technological Advancements - The second-generation high-throughput wireless invasive BCI system developed by the Chinese Academy of Sciences allows high-level paraplegic patients to control wheelchairs and other devices using only their thoughts, with a fourfold increase in data reading speed [3] - The establishment of China's first comprehensive clinical trial area for BCIs signifies the standardization and scaling of clinical research in this field, providing ample clinical data support for technological iterations [3] Group 3: Industry Acceleration - The rapid advancements in domestic technology are fueled by a competitive global environment, exemplified by Neuralink's plans for large-scale production of BCI devices and significant reductions in surgical time and costs [4] - The shift from niche research to essential medical applications is driven by the need for effective treatments for patients with spinal cord injuries and other neurological conditions, marking a revolutionary breakthrough in life sciences [4] Group 4: Caution Amidst Enthusiasm - Despite the excitement in the capital markets, the BCI field is still in a critical phase of clinical validation, with significant challenges remaining before large-scale commercialization can be achieved [5] - The complexity of the human brain presents a major challenge for accurately capturing and interpreting neural signals, with projections indicating that recording from one million neurons may not be feasible until 2100 [5] Group 5: Long-term Value of Technological Progress - The stock market surge in the BCI sector represents a forward-looking vote of confidence in breakthroughs in life sciences technology, which has the potential to transform the lives of millions suffering from neurological diseases [6] - As China transitions from a follower to a competitor in the BCI field, ongoing clinical breakthroughs and technological innovations are paving the way for new possibilities in human health [6]

据报道，脑机接口公司强脑科技将以保密形式提交香港IPO申请。今天，脑机接口概念股集体上涨，南 京熊猫6天5板，道氏技术封涨停。另据此前报道，强脑科技已完成约20亿元人民币融资，为脑机接口领 域除马斯克旗下Neuralink以外的世界第二大规模融资。值得一提的是，其投资人阵容强大，包括IDG、 由英特尔CEO陈立武创立的华登国际，"果链"巨头蓝思科技、领益智造，战略投资方韦尔股份、润泽科 技、华住集团、好未来集团等。强脑科技与DeepSeek，宇树科技等科技企业并称为"杭州六小龙"，是全 球极其少数实现脑机接口产品规模性量产的企业。另外，脑机交互与人机共融海河实验室主任明东表 示，脑机接口在医疗健康、消费电子、军事航天等多个领域展现出巨大的应用前景和市场潜力。 ...

事关政府投资基金，四部门重磅发文。 1月12日，国家发展改革委等四部门联合印发《关于加强政府投资基金布局规划和投向指导的工作办法(试行)》（以下简称《工作办法》）。同时，国家 发展改革委也同步出台了《政府投资基金投向评价管理办法（试行）》（以下简称《管理办法》）的通知。 其中提到，主要考察基金投向是否符合支持新质生产力发展，支持的投向领域包括：培育新兴产业、未来产业。新兴产业主要包括新一代信息技术、新能 源、新材料、高端装备、新能源汽车、绿色环保、民用航空和船舶与海洋工程装备等领域；未来产业主要包括元宇宙、脑机接口、量子信息、人形机器 人、生成式人工智能、生物制造、生物育种、未来显示、未来网络、新型储能等领域。 四部门重磅发布 1月12日，国家发展改革委、财政部、科技部、工业和信息化部联合发布《关于加强政府投资基金布局规划和投向指导的工作办法》（以下简称《工作办 法》）。国家发展改革委相关负责人表示，这是首次在国家层面对政府投资基金的布局和投向作出系统规范。 据央视新闻，《工作办法》围绕政府投资基金"投向哪、怎么投、谁来管"三方面，提出14项政策举措。 在优化基金布局方面，要求基金支持重大战略、重点领域和市场 ...

Investment Rating - The investment rating for the industry is "Positive" and the rating has been maintained [1] Core Insights - The pharmaceutical and biotechnology industry index increased by 5.60%, ranking 8th among 31 primary industries, outperforming the CSI 300 index which rose by 2.18% [4][16] - The PE (TTM overall method, excluding negative values) for the pharmaceutical and biotechnology industry as of January 9, 2026, is 30.56x, up from 29.20x at the end of the previous period, indicating an upward valuation trend [4][21] - The top three sub-industries in terms of PE are vaccines (47.64x), hospitals (43.33x), and medical devices (39.44x), while pharmaceutical circulation has the lowest valuation at 15.42x [4][21] Industry Review - The report highlights significant developments in the pharmaceutical sector, including the release of the "Fourth Batch of Encouraged Generic Drug Catalog" aimed at optimizing the drug supply guarantee system and enhancing industry structure [6][26] - The report notes that 43 listed companies in the pharmaceutical and biotechnology sector experienced a net reduction in shareholder holdings amounting to 2.779 billion yuan, with 8 companies increasing holdings by 20 million yuan and 35 companies reducing holdings by 2.799 billion yuan [4] Important Industry News - The National Health Commission and other departments released the "Fourth Batch of Encouraged Generic Drug Catalog," which includes 21 varieties and 47 specifications, focusing on clinical needs and disease burdens [26][27] - The NMPA announced measures to strengthen the supervision and management of entrusted drug production, aiming to enhance drug quality assurance levels [29][30] - The NMPA also optimized the review and approval process for urgently needed overseas drugs, encouraging simultaneous global development and submission [31][32] Investment Recommendations - The report suggests focusing on innovative pharmaceutical companies with strong pipeline differentiation, rapid clinical advancement, and robust overseas collaboration capabilities [7][8] - In the medical device sector, it recommends paying attention to companies with solid technical foundations and deep collaborations with leading hospitals and research institutions [8]

A股走到今天，我们应该要明白一点，那就是股市已经往大牛市的预期去走了，夸张点甚至可以说是有点像15年大牛市，今天两市成交额为3.64万亿，突破 此前"924行情"创下的3.49万亿最高纪录，要知道今天证券、"易中天"、新能源等权重股都没怎么表现，纯粹是商业航天、AI应用等题材堆出来的；然后今 天上证指数续写17连阳记录；最后周末的20万颗卫星，这个消息周五就有了，周末高度发酵，按以往来说涨这多后资金肯定会借机出货，但今天商业航天依 然暴涨。 种种迹象表示A股做多热情彻底被点燃了。 周末大家应该有看到这张图，今天这么一暴涨，估计晚上又要发酵了，这会不会进一步强化大水牛的预期？ 周末中信证券的策略写的比较好： 很多机构去年年度减仓了、准备等开年大盘调整再上车，但谁知道年初增量资金强劲指数继续连阳，这里机构就慌了被迫追回来了，另外去年的赚钱效应、 和年初指数的连阳强势信号，又吸引了更多的资金进场。 周末的文章有跟大家提过，除了商业航天外，AI应用是最热门的板块，特别是geo概念。我在周五的文章特地写过：机构认为互联网流量红利已完成三 次关键迭代:2000年起搜索流量时代催生SEO、淘宝客机遇;随后推荐流量时代成就短 ...

Core Viewpoint - A-shares have witnessed a historic surge, with trading volumes reaching unprecedented levels, indicating strong market momentum and investor confidence in various sectors, particularly in commercial aerospace and AI applications [1][3]. Group 1: Market Performance - On January 12, the Shanghai Composite Index broke through 4150 points, with trading volumes exceeding 3.6 trillion yuan, marking a significant increase of 478.7 billion yuan from the previous trading day [1]. - The trading volume surpassed 2 trillion yuan for the second consecutive day and exceeded 3 trillion yuan for the first time since October 8, 2024 [1]. Group 2: Leverage and Fund Inflows - In the first week of January, net inflows of leveraged funds reached 85.779 billion yuan, ranking fifth in A-share history for weekly inflows [3]. - The margin trading balance hit a record high of 26,276.01 billion yuan, accounting for 2.55% of the A-share market's circulating market value [3][5]. Group 3: Sector Analysis - All sectors except utilities and food and beverage saw significant net inflows of leveraged funds, with the electronics sector leading at 15.812 billion yuan, followed by non-ferrous metals at 9.562 billion yuan, and defense and military at 9.173 billion yuan [5]. - The number of margin trading accounts reached a decade-high, with 1.5421 million new accounts opened in 2025, reflecting a 52% increase from 2024 [5]. Group 4: Future Market Outlook - According to CITIC Securities, the current market excitement is driven by pent-up demand from investors, with expectations of continued momentum in thematic sectors until the National People's Congress [6]. - Huatai Securities suggests that while the spring market may still have room for growth, the concentration of trading structures indicates a potential shift towards rotation among hot sectors [6][7]. - The potential new marginal drivers for A-shares include abnormal inflows into A500 ETF, the appreciation of the yuan reflecting international confidence, and active themes such as AI and commercial aerospace [7].